Development of Chronic Heart Failure Model Caused by Inflammatory Cytokines and Establishment of Prophylactic and Therapeutic Strategies for the Heart Failure
Development of Chronic Heart Failure Model Caused by Inflammatory Cytokines and Establishment of Prophylactic and Therapeutic Strategies for the Heart Failure
批准号:
08557050
负责人:
SHIMOKAWA Hiroaki
金额:
$4.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
(1)We have developed a canine model of sustained myocardial dysfunction, in which interleukin-1beta (lL-1beta) bound to microspeheres (MS) was selectively injected into the left main coronary artery. This novel model is unique as the long-term effect of an inflammatory cytokine on the heart can be examined without causing its systemic effect. In this model, sustained left ventricular (LV) dysfunction was noted in animals that received IL-1beta-MS but not in those that received MS alone.(2)First, the role of adhesion molecules was examined. When the adhesion molecule inhibitor, SLeX-oligosaccharide (SLeX-OS), or the P-selectin inhibitor, PB1.3, was pre-administered, the leukocyte infiltration and sustained LV dysfunction caused by IL-1beta were markedly inhibited, indicating the important role of adhesion molecules in this model.(3)Second, the role of nitric oxide (NO) derived from inducible NO synthase (iNOS) was examined. When the non-specific protein synthase inhibitor, dexamethasone … More (DEX), or the iNOS inhibitor, aminoguanidine (AG), was pre-administered, the IL-beta-induced sustained myocardial dysfunction was markedly prevented, indicating the important role of iNOS-derived NO in the pathogenesis of the myocardial dysfunction in this model.(4)Third, the role of superoxide anion was examined. When the superoxide anion synthesis inhibitor, OPC-6535, was pre-administered, the IL-1beta-induced sustained myocardial dysfunction was markedly prevented, indicating that superoxide anion may also play an important role in our model.(5)Finally, we measured the myocardial concentrations of nitrotyrosine as a marker for peroxynitrite production as a result of the interaction between NO and superoxide anion. Superoxide anion is known to be a more cytotoxic factor than NO or superoxide anion. The results showed that nitrotyrosine formation was increased in the IL-beta group, whereas the formation was markedly inhibited in the SLeX-OS, PB 1.3, DEX, AG, and OPC-6535 groups. There was a significant correlation between he myocardial concentrations of nitrotyrosine and LV dysfunction, indicating that peroxynitrite is at least one of the major causative factors for the myocardial dysfunction in our model in vivo. Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shimokawa H et al.: "Cytokine generation capacities of monocytes are reducedin patients with severe heart failure." American Heart Journal. 136. 991-1002 (1998)
Shimokawa H 等人:“严重心力衰竭患者的单核细胞的细胞因子生成能力降低。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimokawa H: "Acute myocardial infarction and cytokines." Journal of Immunology and Immuno-Pharmacology. 18. 30-34 (1998)
Shimokawa H:“急性心肌梗死和细胞因子。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimokawa H et al.: "Chronic treatment with interleukin-1β induces coronary intimal lesions and……" Journal of Clinical Investigation. 97. 769-776 (1996)
Shimokawa H 等人:“用白细胞介素 1β 进行慢性治疗会引起冠状动脉内膜损伤并……”《临床研究杂志》97. 769-776 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimokawa H,et al.: "Chronic treatment with interleukin-1 β induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derivedgrowth factor." Journal of Clinical Investigation. 97. 769-776 (1996)
Shimokawa H 等人:“白细胞介素 1 β 的长期治疗会诱导猪体内冠状动脉内膜损伤和血管痉挛反应。血小板衍生生长因子的作用。临床研究杂志 97. 769-776 (1996)”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimokawa H: "Endothelial dysfunction in hypertension." Journal of Atherosclerosis and Thrombosis.4. 118-127 (1998)
Shimokawa H:“高血压的内皮功能障碍。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
The possibility of pleiotropic effects of Novel Oral Anticoagulants (NOAC) on Rho-kinase-cyclophilin A System
-
批准号:25670379
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2013
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
The role of SmgGDS in the pleiotropic effects by statins
-
批准号:23659071
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2011
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Molecular mechanisms for NOSs-mediated responses in microvessels
-
批准号:22390154
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2010
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Experimental and Clinical Studies on the Significance of Endothelium-Derived Hyperpolarizing Factor (EDHF)
-
批准号:16209027
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.7万
-
财政年份:2004
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
International Collaboration Study on the Racial Difference in Coronary Vasospasm
-
批准号:15256003
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$22.3万
-
财政年份:2003
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Development of Nanomedicine for the Treatment of Cardiovascular Diseases
-
批准号:13557068
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.83万
-
财政年份:2001
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Role of Rho/Rho-kinase-mediated pathway in the pathogenesls of atherosclerosis
-
批准号:13307024
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$35.19万
-
财政年份:2001
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Basic and clinical studies on the role of inflammatory mechanisms in the pathogenesis ischemic heart disease
-
批准号:12470158
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2000
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
The role of inflammatory mechanisms in the pathogenesis of ischemic heart disease. Basic and clinical studies.
-
批准号:07457173
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1995
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
Role of Inflammatory Cytokines in the Development and Progression of Ischemic Heart Diseases-Experimental and Clinical Studies-
-
批准号:05454274
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1993
-
负责人:SHIMOKAWA Hiroaki
-
依托单位:
海外基金